Acute aortic dissection

T Carrel, TM Sundt, Y von Kodolitsch, M Czerny - The Lancet, 2023 - thelancet.com
Although substantial progress has been made in the prevention, diagnosis, and treatment of
acute aortic dissection, it remains a complex cardiovascular event, with a high immediate …

2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint …

Writing Committee Members, EM Isselbacher… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

Genetics and mechanisms of thoracic aortic disease

E Chou, JP Pirruccello, PT Ellinor… - Nature Reviews …, 2023 - nature.com
Aortic disease has many forms including aortic aneurysm and dissection, aortic coarctation
or abnormalities in aortic function, such as loss of aortic distensibility. Genetic analysis in …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Distinct Mechanisms of β-Arrestin–Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm and Associated Mortality

ZP Jara, TJ Harford, KD Singh, R Desnoyer… - …, 2023 - Am Heart Assoc
Background: Aortic aneurysm (AA) is a “silent killer” human disease with no effective
treatment. Although the therapeutic potential of various pharmacological agents have been …

Efficacy and safety of sacubitril/valsartan in chronic Type B aortic dissection combined with mild hypertension

X Wang, F Song, L Jiang, Z Huang… - American Journal of …, 2024 - academic.oup.com
Background Optimal antihypertensive medication for chronic Type B aortic dissection
remains undecided. This study compared the efficacy and safety of sacubitril/valsartan with …

[HTML][HTML] 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease

JA Beckman, WC Members - Journal of the American College of …, 2022 - ncbi.nlm.nih.gov
AIM The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease”
provides recommendations to guide clinicians in the diagnosis, genetic evaluation and …

Durability of biological valves implanted in aortic or mitral positions: a nationwide cohort study

CY Chen, CP Lin, KC Hung, YH Chan, VCC Wu… - The Annals of Thoracic …, 2023 - Elsevier
Background Biologic prostheses are being increasingly used for aortic and mitral valve
replacement (AVR and MVR). This study evaluated the long-term durability of bioprosthetic …

[HTML][HTML] Cardiovascular outcomes in kidney transplant recipients with ADPKD

M Chedid, HD Kaidbay, S Wigerinck… - Kidney International …, 2022 - Elsevier
Introduction Cardiovascular disease leads to high morbidity and mortality in patients with
kidney failure. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic …

[HTML][HTML] Evaluating prescription pattern and effectiveness of antihypertensive drugs in non-operated aortic dissection patients

YH Huang, KL Chiu, CW Shen, MJ Bair… - Journal of Clinical …, 2023 - mdpi.com
Introduction: Aortic dissection (AD) is a life-threatening disease. However, the effectiveness
of different strategies of antihypertensive therapies in non-operated AD patients is still …